Harmony Biosciences Holdings, Inc. (HRMY) Fundamentals — Income, Balance Sheet & Cash Flow | MarketCI

Harmony Biosciences Holdings, Inc. (HRMY) Fundamentals — Income, Balance Sheet & Cash Flow | MarketCI | MarketCI

HRMY

Market Closed

Harmony Biosciences Holdings, Inc.

NASDAQHealthcare Biotechnology

293 employees

CEO: Jeffrey Dayno

Founded: 2020

$35.32

+$0.00(+NaN%)

Market Cap

2.04B

Beta

0.94

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

Financial Statements

Comprehensive breakdown of financial statements and performance metrics

Gross Margin

77.2%

20.1%

CAGR: 28.0%

Profit after direct costs

Operating Margin

24.0%

9.2%

CAGR: 24.2%

Core business profitability

Net Margin

18.3%

9.1%

CAGR: 46.3%

Bottom line profitability

Revenue Growth

21.5%

YoY

CAGR: 29.9%

Top line growth rate

Revenue Flow Analysis

Visual flow showing how HRMY allocates revenue across expenses and profit

Fiscal Year 2025

Revenue Distribution

Flow of revenue through cost categories to net income

Gross Margin

77.2%

$670.11M

Operating Margin

24.0%

$208.47M

Net Margin

18.3%

$158.69M

Detailed Income Statement

Complete profit and loss breakdown with margin analysis and historical comparison

Item	2021	2022	2023	2024	2025	YoY Change
Total Revenue	305.44M	437.86M	582.02M	714.73M	868.45M	21.5%
Cost of Revenue	(55.52M)	(83.48M)	(121.24M)	(156.81M)	(198.34M)	26.5%
Gross Profit	249.92M	354.37M	460.79M	557.92M	670.11M	20.1%
Operating Expenses
Research & Development	(30.37M)	(70.89M)	(76.06M)	(145.82M)	(189.59M)	30.0%
Selling, General & Administrative	(132.03M)	(163.30M)	(192.69M)	(221.27M)	(272.05M)	22.9%
General & Administrative	(63.91M)	(84.02M)	(95.29M)	(110.35M)	(152.54M)	38.2%
Selling & Marketing	(68.12M)	(79.28M)	(97.40M)	(110.92M)	(119.51M)	7.8%
Depreciation & Amortization	(18.84M)	(23.39M)	(24.36M)	(24.11M)	(25.34M)	5.1%
Operating Income (EBIT)	87.53M	120.19M	192.03M	190.83M	208.47M	9.2%
Non-Operating Items
Interest Income	224.00K	3.13M	14.73M	18.54M	21.92M	18.2%
Interest Expense	(24.19M)	(18.80M)	(23.76M)	(17.50M)	(14.65M)	-16.3%
Other Income/Expenses (Net)	-50.10M	-15.50M	-18.63M	978.00K	6.59M	574.3%
Income Before Tax	37.43M	104.69M	173.40M	191.80M	215.06M	12.1%
Income Tax Expense	(2.83M)	(76.78M)	(44.54M)	(46.31M)	(56.38M)	21.7%
Net Income	34.60M	181.47M	128.85M	145.49M	158.69M	9.1%
Per Share Metrics
Earnings Per Share (Basic)	$1	$3	$2	$3	$3	7.8%
Weighted Avg Shares Outstanding	57.53M	59.17M	59.47M	56.88M	57.49M	1.1%
Weighted Avg Shares Outstanding (Diluted)	59.21M	61.10M	60.37M	57.87M	58.54M	1.2%
EBITDA	80.46M	146.87M	221.51M	233.41M	255.05M	9.3%

Explore HRMY

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

HRMY in the Healthcare

Mid Cap

Healthcare

Browse sector stocks →

Biotechnology

Browse industry stocks →